Chlorogenic acid prevents isoproterenol-induced DNA damage in vascular smooth muscle cells.

Numerous clinical therapeutic agents have been identified as DNA damaging. The present study revealed that isoproterenol (Iso) resulted in DNA damage in vascular smooth muscle cells (VSMCs) and increased the levels of intracellular oxygen free radicals. Administration of chlorogenic acid (CGA) inhibited this effect. Pretreatment with CGA abrogated the increase in protein expression levels of γ‑H2A histone family member X, phosphorylated ataxia telangiectasia mutated, phosphorylated Rad3‑related protein, breast cancer 1 and C‑terminal Src homologous kinase induced by Iso. In addition, the increase in levels of intracellular reactive oxygen species (ROS) induced by Iso was inhibited by CGA pretreatment in a dose‑dependent manner. The results of the present study suggest that CGA may inhibit Iso‑induced VSMC damage via the suppression of ROS generation. Therefore, CGA may be a novel agent for the treatment of vascular diseases.

Introduction

Various types of DNA lesions may result in genomic instability. To rectify this situation, cells activate the DNA damage response to recognize and repair DNA lesions (1). However, when complete repair of the damage is not achieved, the accumulation of unrepaired DNA damage may result in various diseases, including cancer (2), immunodeficiency (3) and cardiovascular disease (4). The primary causes of DNA damage may be divided into exogenous and endogenous factors, the latter of which primarily arise due to intracellular oxidative stress. Free radicals are a class of substances containing unpaired electrons, of which oxygen free radicals account for ~95%. Free radicals are generated in three ways: i) Cracking of covalent bonds, ii) single-electron loss and iii) single-electron gain. On entering the body, a large proportion of oxygen is utilized by the respiratory chain, whereas 2–3% is catalyzed by oxidase and further converted to reactive oxygen species (ROS), the majority of which is eliminated by antioxidant enzymes and molecules (1,5,6). However, excessive ROS, which may occur following the breakdown of the body homeostasis of oxidation and antioxidation, may attack double-stranded DNA and impair DNA repair mechanisms, resulting in DNA breakage and nucleotide modifications (7).

Atherosclerosis (AS) is a primary cause of mortality and morbidity in high-income countries (8). It is predicted that the mortality rate of atherosclerosis will surpass that of infectious diseases by 2020 (9). In recent years, studies on signal transduction and gene regulation have revealed that oxidative stress and inflammation are two key elements in AS occurrence. ROS and oxidized low density lipoprotein are the primary causes of endothelial injury and excessive production of inflammatory cytokines. In addition, by increasing growth factors such as platelet derived growth factor, ROS indirectly transform vascular smooth muscle cells (VSMCs) from a contractile to a synthetic phenotype. Synthetic phenotype VSMCs synthesize collagen and elastic fibers, producing a fibrous cap surrounding the lipid pool and forming a typical atherosclerotic plaque. As the fibrous cap ages, it becomes thinner and more prone to rupture (10). Matthews et al (11) revealed that oxidative stress may lead to DNA damage in VSMCs by the breakage of DNA strands, oxidative modification of guanine and regulation of associated enzyme activity, and ultimately affect the occurrence and progression of AS.

Numerous therapeutic agents have been demonstrated to stimulate DNA damage (12–14). Isoproterenol (Iso), a synthetic catecholamine and potent vasodilator, is widely administered in cardiac arrest and shock (15,16). However, it has been demonstrated to induce DNA damage in cardiomyocytes and results in cardiac wall hypertrophy (17,18). Kim et al (19) demonstrated that Iso elevated levels of intracellular ROS and increased cerebrovascular damage.

The present study aimed to assess the prevention of Iso-induced vascular damage via treatment with a compound present in various herbs. Chlorogenic acid (CGA) is a naturally occurring polyphenol, which is the main active ingredient in traditional Chinese medicine honeysuckle and eucommia leaves and is present in sunflower seeds, fruits, vegetables, soybeans, wheat and coffee beans. CGA has anticancer, anti-inflammatory and anti-oxidative activities (20–22). CGA is formed by the condensation of caffeic acid and quinic acid, two phenolic compounds. As it has phenolic hydroxide groups, CGA is highly reductive and extremely vulnerable to oxidation, enabling it to scavenge free radicals and affect anti-lipid peroxidation.

In the present study, Iso-induced DNA damage in VSMCs and the levels of intracellular ROS were analyzed, and the protective effect of CGA pretreatment on this damage was investigated.

Materials and methods

Reagents

Iso, CGA, collagenase II and trypsin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Primary rabbit antibodies against phosphorylated (p) ataxia telangiectasia mutated (ATM; catalog no. 13050), p-Rad3-related protein (ATR; catalog no. 2853), p-breast cancer 1 (BRCA1; catalog no. 9009), p-C-terminal Src homologous kinase 2 (Chk2; catalog no. 2197), γ-H2A histone family member X (γ-H2AX; catalog no. 2595) and TATA binding protein (TBP; catalog no. 8515) were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Mouse anti-α-smooth muscle actin (α-SMA; catalog no. A5228), which is a vascular-specific capture antibody, was obtained from Sigma-Aldrich. Rabbit anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; catalog no. 5632-1) was purchased from Epitomics (Burlingame, CA, USA). Fluorescein isothiocyanate (FITC) -conjugated goat anti-mouse IgG (catalog no. sc-2010) was obtained from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). HRP-labeled goat anti-rabbit IgG (catalog no. A0208) and cell lysis buffer were purchased from Beyotime Institute of Biotechnology (Haimen, China). The bicinchoninic acid (BCA) protein quantitation kit was obtained from Pierce; Thermo Fisher Scientific, Inc. (Waltham, MA, USA). The SuperSignal chemiluminescence substrate kit was purchased from EMD Millipore (Billerica, MA, USA). All other chemicals used were of analytical grade.

Isolation and culture of VSMCs

A total of 22 C57BL/6 female mice was obtained from Shanghai Slac Laboratory Animal Co. Ltd. (Shanghai, China) and maintained in specific pathogen-free conditions at 22–26°C under a 12-h light/dark cycle, with ad libitum access to food and water, at Tongji University (Shanghai, China). The protocol was approved by the Institutional Animal Care and Use Committee of Tongji University (Shanghai, China). The thoracic aorta was removed from 4- to 5-week-old mice following sacrifice by cervical dislocation. The aorta was digested with 1 mg/ml collagenase II and 100 µg/ml trypsin at 37°C for 40 min. Following digestion, cells were pelleted at 3,000 × g for 6 min at room temperature, and plated in Dulbecco's modified Eagle's medium (DMEM; Wisent, Inc., St. Bruno, QC, Canada) containing 1 g/l glucose, 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.) and 1% penicillin/streptomycin (Gibco; Thermo Fisher Scientific, Inc.). Cells were cultured in a humidified incubator with 5% CO2 at 37°C. Every 48 h, cells were washed with phosphate-buffered saline (PBS) three times and placed in fresh media. Primary cells following the second passage were used for experiments.

Immunofluorescence identification of isolated cardiomyocytes

Cultured VSMCs were washed twice with PBS and fixed in 4% paraformaldehyde solution (Sangon Biotech Co., Ltd., Shanghai, China) at room temperature for 20 min. Following fixation, VSMCs were washed with PBS to remove the fixative and immersed in 0.5% (v/v) Triton-X-100 (Sigma-Aldrich) in PBS for 5 min to achieve permeability. VSMCs were then washed with 0.5% Tween® 20 in PBS (PBST) three times and immersed in 5% bovine serum albumin (BSA; Sigma-Aldrich) in PBS for 1 h at 37°C. VSMCs were washed twice with PBST and incubated with the anti-α-SMA antibody diluted 1:100 in 2% BSA in PBS and covered with Parafilm overnight at 4°C. The primary antibody was removed via three washes with PBST. Subsequently, a FITC-conjugated secondary antibody at a dilution of 1:200 in 2% BSA was added and incubated at room temperature for 1 h in the dark. The secondary antibody was removed via washing three times in PBST for 5 min, and cells were stained with 4′,6-diamidino-2-phenylindole (DAPI) solution at room temperature in the dark for 20 min. The staining solution was removed and the cells washed with PBST. Anti-fade mounting medium was added and cell imaging was performed under a fluorescence microscope (Olympus Corporation, Tokyo, Japan). Identification of VSMCs was confirmed by morphological observation. The majority of the VSMCs cultured in vitro exhibited a fusiform shape with a large nucleus and defined fiber filaments.

Cytotoxicity of Iso and CGA on VSMCs

Cell viability was measured by a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Iso (0, 1, 5, 10, 15, 20 or 25 µM) and CGA (0, 10, 50, 100, 150 or 200 µM) were added to a 96-well plate containing adhesive VSMCs (5,000 cells/well), with 6 wells for each concentration. Following incubation in a 5% CO2 incubator at 37°C for 12 h, the medium in each well was removed and the cells were washed twice with PBS. MTT solution (20 in 100 µl DMEM) was added to each well and the plate was incubated in a 5% CO2 incubator at 37°C for 4 h. The medium was removed and 150 µl dimethyl sulfoxide (Sangon Biotech Co., Ltd.) was added to each well on a micro-oscillator (Kylin-Bell Lab Instruments Co., Ltd., Haimen, China); the plate was shaken for 10 min to dissolve the crystals. The absorbance in each well was read using a Multiskan FC microplate reader (Thermo Fisher Scientific, Inc.) at a wavelength of 570 nm.

Western blot analysis

Following treatment, medium was removed and the cells were washed three times with PBS. Cells were lysed in cell lysis buffer containing 1% phenylmethylsulfonyl fluoride (PMSF; Beyotime Institute of Biotechnology) for 30 min on ice and centrifuged at 14,000 × g for 10 min at 4°C. Nuclear proteins were extracted from Iso-treated cells using a nuclear and cytoplasmic protein extraction kit (Beyotime Institute of Biotechnology) containing 1% (v/v) PMSF. The total protein contents were quantified with a BCA protein assay kit to ensure equal protein loading (~50 µg protein) in each well prior to gel electrophoresis. The prepared samples were boiled in 5X sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample loading buffer (Beyotime Institute of Biotechnology) for 5 min. The samples were separated on 10% SDS-PAGE gels and transferred to polyvinylidene difluoride membranes. Membranes were blocked for 1 h in 5% non-fat milk in Tris/HCl-buffered saline containing 1% Tween 20 and 0.8% NaCl (TBST) at room temperature and then incubated overnight with appropriate primary antibodies at 4°C. The dilution of all primary antibodies was 1:1,000, except the anti-GAPDH antibody, which was diluted to 1:5,000. Following washing with TBST, the membranes were incubated with the HRP-conjugated secondary antibody (1:3,000) for 1 h at room temperature. The membranes were rinsed and soaked in SuperSignal chemiluminescence substrate kit. Immunoreactive bands were visualized with a chemiluminescence imaging analyzer and Quantity One® software version 4.6.2 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Measurement of ROS

The level of intracellular ROS following Iso and CGA treatment was measured using a fluorescent probe, 2′,7′-dichloro-dihydro-fluorescein diacetate (DCFH-DA; Reactive Oxygen Species assay kit; Beyotime Institute of Biotechnology), as described previously (23). In brief, cells were loaded with serum-free medium containing 10 µM DCFH-DA (v/v, 1:1,000) and incubated at 37°C for 30 min. The residual DCFH-DA solution was removed and cells were washed three times with serum-free medium for 5 min, and then with PBS. Cells were observed under a fluorescence microscope (Olympus Corporation) equipped with a charge-coupled device camera (Hamamatsu Photonics K.K., Hamamatsu, Japan). Quantification of the fluorescence intensity was performed using ImageJ software version 1.42 (National Institutes of Health, Bethesda, MD, USA). The data are expressed as percentages compared with the control intensity.

Statistical analysis

Statistical analyses were performed using SPSS software version 14.0 (SPSS, Inc., Chicago, IL, USA). Groups were compared using one-way analyses of variance and Fisher's protected least significant difference test. All data are expressed as the mean ± standard deviation. P<0.05 was considered to indicate a statistically significant difference. The experiments were repeated at least three times independently.

Results

High-purity isolation of VSMCs

Immunofluorescence staining using an α-SMA antibody and a FITC-conjugated secondary antibody was performed to determine whether the isolated cells were high-purity VSMCs. Cells were counterstained with DAPI, which penetrates the cell membrane and binds to double-stranded DNA, fluorescing blue. α-SMA positive cells accounted for >95% of total cells from at least five fields of view, indicating the high purity of VSMCs (Fig. 1). In addition, VSMCs isolated following 48 h in culture exhibited discernible fiber filaments and a well-formed spindle shape.

Figure 1.

Immunofluorescence staining of isolated VSMCs. VSMCs were stained with an α-SMA antibody and a fluorescein isothiocyanate-conjugated secondary antibody and counterstained with 4′,6-diamidino-2-phenylindole. The majority of cells were positive for α-SMA, and exhibited discernible fiber filaments and a well-formed spindle shape, verifying the high purity of isolated VSMCs. Magnification, ×20. VSMCs, vascular smooth muscle cells; α-SMA, smooth muscle α-actin.

Effects of Iso and CGA on cell viability

Cell viability was determined using an MTT assay, which determined the optical density (OD) values of Iso-and CGA-treated cells to be between 0.3 and 0.5 (Fig. 2A and B, respectively). OD values between 0 and 0.7 are consistent with the linear association of cell viability. The percentage of cell viability was calculated relative to control wells designated as 100% viable. The results revealed that concentrations of Iso ranging from 1 to 25 µM and CGA ranging from 10 to 200 µM did not significantly affect cell viability compared with the control (Fig. 2C and D, respectively). Therefore, the effects of Iso and CGA observed in subsequent experiments were not due to cell toxicity.

Figure 2.

Effect of Iso and CGA on cytotoxicity and vascular smooth muscle cell viability. Cell viability was determined using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, which determined the absorbance of cells following treatment with various concentrations of (A) Iso and (B) CGA. The percentage of cell viability was calculated relative to control wells designated as 100% viable, for (C) Iso-and (D) CGA-treated cells. Iso, isoproterenol; CGA, chlorogenic acid.

CGA protects VSMCs from Iso-induced DNA damage

γ-H2AX, a double-stranded DNA break marker of DNA damage, is expressed in the nuclei of cells. TBP served as the loading control for nuclear proteins. Following treatment of VSMCs with 10 µM Iso for 48 h, the protein expression level of γ-H2AX increased significantly by 2.1-fold (P=0.0012; Fig. 3A). However, pretreatment with 50 µM CGA significantly inhibited Iso-induced γ-H2AX upregulation by 50% compared with the Iso group without CGA pretreatment (P=0.0081). Furthermore, almost no change in γ-H2AX was visible compared to the control group following 100 µM CGA pretreatment of the Iso-induced VSMCs (P=0.1050). These results indicated that CGA may inhibit Iso-induced DNA strand breaks.

Figure 3.

DNA damage following treatment of vascular smooth muscle cells with Iso, in the presence or absence of CGA pretreatment, as determined by western blot analysis. (A) Alterations in the protein expression levels of the nuclear protein γ-H2AX. TBP served as a loading control. (B) Alterations in the protein expression levels of p-ATR, p-ATM, BRCA-1 and Chk2. GAPDH served as a loading control. The western blot represents one of at least three independent experiments that demonstrated similar results. *P<0.05 vs. control. Iso, isoproterenol; CGA, chlorogenic acid; γ-H2AX, γ-H2A histone family member X; TBP, TATA binding protein; p, phosphorylated; ATR, Rad3-related protein; ATM, ataxia telangiectasia mutated; BRCA1, breast cancer 1; Chk2, C-terminal Src homologous kinase 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

To investigate the signaling pathway of Iso-induced DNA damage, alterations in the protein expression levels of DNA damage-associated proteins were observed. There were similar trends in the protein expression levels of p-ATM, p-ATR, p-BRCA1 and p-Chk2, which reflected changes in γ-H2AX expression. Iso treatment induced significant upregulation of these DNA damage associated proteins relative to the control (p-ATM, P=0.0023; p-ATR, P=0.0015; p-BRCA1, P=0.0013; p-Chk2, P=0.0020). Following CGA pretreatment, Iso-induced DNA damage was notably reduced in VSMCs (Fig. 3B). The inhibition of DNA damage-induced upregulation of p-ATM, p-ATR, p-BRCA1 and p-Chk2 expression levels was CGA dose-dependent. These results suggested that CGA may inhibit Iso-induced DNA damage checkpoint arrest.

CGA reduces Iso-induced ROS in VSMCs

It has previously been reported that there is an association between inflammation and ROS (24,25), and that CGA scavenges oxygen free radicals in cells (26,27). Therefore, ROS levels were examined in VSMCs treated with Iso in the absence or presence of CGA treatment. Following Iso treatment, the level of ROS significantly increased in VSMCs after 48 h (P=0.0008). Pretreatment with CGA significantly decreased the level of ROS compared with Iso treatment alone (50 µM, P=0.0327; 100 µM, 0.0938; Fig. 4). At 10 µM CGA, the ROS level was reduced from an increase of 2.3-fold to an increase of 1.6-fold relative to untreated cells. Furthermore, 50 µM CGA resulted in a further decrease of ROS levels. At 100 µM CGA, the level of ROS in VSMCs returned almost to the basal level of control cells (Fig. 4). These results indicated that the level of ROS increased during Iso-induced DNA damage and that CGA may inhibit DNA damage by suppressing ROS.

Figure 4.

Levels of ROS in vascular smooth muscle cells following treatment with Iso, in the absence or presence of CGA pretreatment, as measured using a fluorescent probe, 2′,7′-dichloro-dihydro-fluorescein diacetate. ROS levels were measured in (A) control cells, (B) 10 µM Iso-treated cells, (C) 50 µM CGA-and 10 µM Iso-treated cells, and (D) 100 µM CGA- and 10 µM Iso-treated cells. (E) Quantification ROS levels. Scale bars=100 µM. *P<0.05 vs. control. ROS, reactive oxygen species; Iso, isoproterenol; CGA, chlorogenic acid.

Discussion

VSMCs are crucial for maintaining the physiological function and remodeling of blood vessels (28,29). Oxidative stress leading to cell DNA damage can accelerate the aging process in VSMCs, known as stress-induced premature senescence, which plays a crucial role in the process of the formation of AS (30). Therefore, investigation into the effects of Iso on VSMCs and the prevention of DNA damage induced by this therapeutic agent is key. CGA, as an active component of certain Chinese herbal medicines, has been investigated due to its various effects, including anticancer and anti-inflammatory effects. Pang et al (31) revealed that CGA may prevent acetaminophen-induced liver oxidative stress injury via the regulation of cytochrome P450 metabolism enzymes and certain important anti-oxidant signal molecules, including proteins from the peroxiredoxins family. Cha et al (32) demonstrated that CGA reduced UVB-mediated oxidative stress in human HaCaT keratinocytes. The preventive effect of CGA with regards to VSMC damage and inhibition of Iso-induced DNA damage may have important implications in the clinical setting.

The present study revealed that 10 µM Iso may induce DNA damage in VSMCs and increase intracellular ROS. Pretreatment with CGA, particularly at the 100 µM concentration, may effectively block damage to VSMCs induced by Iso through abrogating the increase in protein expression levels of γ-H2AX, p-ATM, p-ATR, p-BRCA1 and p-Chk2 and further preventing ROS formation. In addition, the increase in levels of intracellular reactive oxygen species (ROS) induced by Iso was inhibited by CGA pretreatment in a dose-dependent manner. These results support the findings of previous studies (22,33,34), suggesting that CGA may be a promising drug for protection against vascular diseases. Furthermore, CGA is widely present in plant leaves, flowers and fruits (35,36), which are used as herbal ingredients in certain traditional Chinese medicines. Therefore, CGA may have potential applications for the prevention of DNA damage.